Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2020-07-13 Sale |
2020-07-15 1:22 pm |
Ultragenyx Pharmaceutical Inc. | RARE | KAKKIS EMIL D President & CEO |
40,000 | $85.35 | $3,414,000 | 3,030,782 (Indirect Direct) |
View |
| 2020-07-08 Sale |
2020-07-10 5:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,638 | $91 | $240,058 | 28,582 (Direct) |
View |
| 2020-07-06 Sale |
2020-07-08 12:30 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $90 | $556,290 | 13,550 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 2:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $85 | $425,000 | 19,731 (Direct) |
View |
| 2020-07-01 Sale |
2020-07-06 2:21 pm |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,611 | $81 | $211,491 | 31,220 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2020-07-08 Exercise |
2020-07-10 5:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,000 | $0 | 28,582 (Direct) |
View |
| 2020-07-08 Exercise |
2020-07-10 5:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
2,000 | $21 | 28,582 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $0 | 13,550 (Direct) |
View |
| 2020-07-06 Exercise |
2020-07-08 12:30 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,181 | $21 | 13,550 (Direct) |
View |
| 2020-07-06 Tax Withholding |
2020-07-08 12:29 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
260 | $86.75 | 23,590 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $0 | 19,731 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
5,000 | $21 | 19,731 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A 2024-01-29 |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $0 | 31,220 (Direct) |
View |
| 2020-07-01 Exercise |
2020-07-06 2:21 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Huizenga Theodore Alan SVP, Controller and PAO |
1,500 | $21 | 31,220 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:16 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | WELCH DANIEL G Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:15 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | SULIMAN SHEHNAAZ Director |
6,800 | $0 | 9,800 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:14 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | SIEGALL CLAY B Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:13 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | NARACHI MICHAEL Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:12 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Fust Matthew K Director |
6,800 | $0 | 17,800 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:11 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Ekman Lars Director |
6,800 | $0 | 16,550 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:10 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Dunsire Deborah Director |
6,800 | $0 | 14,675 (Direct) |
View |
| 2020-06-26 Option Award |
2020-06-30 1:10 pm |
N/A 2030-06-26 |
Ultragenyx Pharmaceutical Inc. | RARE | Aliski William Director |
6,800 | $0 | 151,760 (Direct) |
View |
| 2020-06-19 Tax Withholding |
2020-06-22 1:47 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Harris Erik EVP & Chief Commercial Officer |
303 | $78.22 | 23,850 (Direct) |
View |
| 2020-06-20 Tax Withholding |
2020-06-22 1:46 pm |
N/A N/A |
Ultragenyx Pharmaceutical Inc. | RARE | Parschauer Karah Herdman EVP and General Counsel |
649 | $78.22 | 26,663 (Direct) |
View |